//--> //-->

In order to help keep our patients, staff and community healthy during the COVID-19 pandemic, Rutgers Cancer Institute of New Jersey, in partnership with RWJBarnabas Health, is utilizing telemedicine for surveillance and follow-up appointments for existing cancer patients. When appropriate, telemedicine appointments for initial consults for patients with a new cancer diagnosis are also offered.

Andrew M. Evens, DO, MSc, FACP, Associate Director for Clinical Services and Director, Lymphoma Program, Rutgers Cancer Institute of New Jersey; Medical Director, Oncology Service Line, RWJBarnabas Health; and Professor of Medicine, Rutgers Robert Wood Johnson Medical School.
 

Below are some Nursing Education Resources, highlighting online programs.
 

As New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health is the state’s leading authority on cancer. As such, we want to help our patients navigate and better understand how the coronavirus may impact them.